The Great Human Papilloma Virus Vaccine Hoax Exposed  
  
 28 Dec 2007
 Mike Adams
News  Target
 http://www.youtube.com/watch?v=XK97CHQZhq0&eurl=http://www.truthnews.us/?p=1444
 For the last several years, HPV vaccines have been marketed to  the public and mandated in compulsory injections for young girls in several  states based on the idea that they prevent cervical cancer. Now, NewsTarget has  obtained documents from the FDA and other sources (see below) which reveal that  the FDA has been well aware for several years that Human Papilloma Virus (HPV)  has no direct link to cervical cancer.
 NewsTarget has also learned that HPV vaccines have been proven  to be flatly worthless in clearing the HPV virus from women who have already  been exposed to HPV (which includes most sexually active women), calling into  question the scientific justification of mandatory “vaccinate everyone”  policies.
 Furthermore, this story reveals evidence that the vaccine  currently being administered for HPV — Gardasil — may increase the risk of  precancerous cervical lesions by an alarming 44.6 percent in some women. The  vaccine, it turns out, may be far more dangerous to the health of women than  doing nothing at all.
 If true, this information reveals details of an enormous public  health fraud being perpetrated on the American people, involving FDA officials,  Big Pharma promoters, and even the governors of states like Texas. The health  and safety of tens of millions of young girls is at stake here, and what this  NewsTarget investigative report reveals is that HPV vaccinations may not  only be medically useless; they may also be harmful to the health of the young  girls receiving them.
 This report reveals startling facts about the HPV vaccine that  most people will find shocking:
 • How it may actually increase the risk of precancerous lesions  by 44.6 percent.
 • The FDA has, for four years, known that HPV was not the cause  of cervical cancer.
 • Why mandatory HPV vaccination policies may cause great harm to  young girls.
 • Why HPV infections are self-limiting and pose no real danger  in healthy women
 • Little-known FDA documents that reveal astounding facts about  Gardasil
 • How Big Pharma promoted its Gardasil vaccine using disease  mongering and fear mongering
 This story begins at a company called HiFi DNA Tech, LLC  (http://www.hifidna.com) a company involved in the  manufacture of portable HPV testing devices based on DNA sequencing analysis.  HiFi DNA Tech has been pushing to get the FDA to classify its HPV detection  technology as a “Class II” virology testing device. To understand why this is a  big deal, you have to understand the differences between “Class II” and “Class  III” virology testing devices.
 Based on FDA rules, a Class III virology testing device is one  that is considered by the FDA to have “premarket approval,” meaning that it  cannot yet be sold to the public. In order for such a device to be marketed to  the public, it must be downgraded to Class II status, which is considered a  “special controls” status. Class II devices are, “…those devices for which the  general controls by themselves are insufficient to provide reasonable assurance  of safety and effectiveness, but for which there is sufficient information to  establish special controls to provide such assurance, including performance  standards, postmarket surveillance, patient registries, development and  dissemination of guidelines, recommendations, and any other appropriate actions  the agency deems necessary.”
 In other words, a Class II device may or may not actually be  safe, but the FDA considers is safe enough to release to the public.
 HiFi DNA Tech has been trying to get its HPV detection device  downgraded to a Class II device based on the following arguments:
 • For more than 20 years, the FDA had regulated the HPV test as  a “test for cervical cancer.”
 • But since at least 2003, the FDA has changed its position on  the relationship between Human Papilloma Virus and cervical cancer, stating that  the HPV strain is “not associated with cervical cancer.”
 • Accordingly, HiFi DNA Tech is arguing that the HPV test it has  developed is no longer a test for cervical cancer, but is merely a test  for the presence of Human Papilloma Viruses — a shift that makes the  test far more reliable in its primary purpose. In other words, the test is  merely detecting the presence of a virus, not making a diagnosis of a disease  (which would be a much higher standard to meet).
 On October 12, 2007, HiFi DNA Tech sued the Food and Drug  Administration in an attempt to force it to downgrade its HPV detection  technology to Class II (see http://www.news-medical.net/?id=31180 ). Earlier  in the year — on March 7, 2007, HiFi DNA Tech filed the HPV PCR test  reclassification petition with the FDA. It is the information in this  petition document that led us to the FDA’s knowledge that HPV is not linked to  cervical cancer.
 Got all that? This is a somewhat complex story to follow, so  here it is again in summary:
 • A company that manufacturers a DNA testing device that can  detect the presence of HPV (Human Papilloma Virus) is petitioning the FDA (and  suing the FDA) to get it to reclassify its medical device as a “Class II” device  based on the revelation that the FDA has already adopted the position that HPV  infections do not directly cause cervical cancer.
 • This would mean that the FDA has been aware for years  that HPV does not cause cervical cancer, which means that the FDA’s  approval of the Gardasil vaccine — as well as the national push for Gardasil  vaccinations — is based on a grand medical hoax that, not surprisingly, appears  to be designed to exploit the fear of cancer to sell vaccines. The victims in  all this, of course, are the young girls who are apparently being subjected to a  medically useless (and potentially dangerous) vaccine.
 • None of this information was apparently known during the more  recent debates over the safety and efficacy of Gardasil, the HPV vaccine now in  use. This means that the public debate over mandatory HPV vaccinations lacked  key elements that now seem essential to reaching rational, evidence-based  conclusions over the safety and efficacy of such vaccines.
 Next, we reveal the FDA’s statement that HPV is “not associated  with cervical cancer.”
 The Reclassification Petition, dated March 7, 2007, is still  posted on the FDA’s website: http://www.fda.gov/ohrms/dockets/dockets/07p0210/07p-0210-ccp0001-01-vol1.pdf
 In case the FDA removes this document (as it has been known to  do), we’ve posted a backup copy of the document on our own servers: http://www.NewsTarget.com/downloads/FDA-HPV.pdf
 This document reveals the following text:
 The FDA news release of March 31, 2003 acknowledges that  “most infections (by HPV) are short-lived and not associated with cervical  cancer”, in recognition of the advances in medical science and technology since  1988. In other words, since 2003 the scientific staff of the FDA no longer  considers HPV infection to be a high-risk disease when writing educational  materials for the general public whereas the regulatory arm of the agency is  still bound by the old classification scheme that had placed HPV test as a test  to stratify risk for cervical cancer in regulating the industry.
 NewsTarget sought to verify the existence of the FDA news  release referenced by this petition reclassification document and found that,  indeed, the FDA news release exists. In fact, it’s still posted on the FDA  website at http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html
 In it, the FDA says, “The HPV DNA test is not intended to  substitute for regular Pap screening. Nor is it intended to screen women under  30 who have normal Pap tests. Although the rate of HPV infection in this group  is high, most infections are short-lived and not associated with  cervical cancer.” (Emphasis added.)
 In other words, the FDA knew in 2003 that HPV infections are not  associated with cervical cancer.
 Furthermore, the FDA states, in the same press release, “Most  women who become infected with HPV are able to eradicate the virus and suffer no  apparent long-term consequences to their health.”
 In other words, HPV infections do not cause cervical  cancer! Remember, the entire push for mandatory HPV vaccinations of  young girls across the country has been the urgent call to “save” these young  girls from cervical cancer. The vaccine push has been about “savings lives.” But  as these documents clearly reveal, HPV is no threat to the lives of young girls.  In fact, as you will see below, HPV infections are naturally  self-limiting!
 HPV Infections Resolve Themselves, Without  Vaccines
 As the reclassification petition reveals, HPV infections are  naturally self-limiting — meaning that they are controlled naturally, without  requiring intervention with drugs or vaccines. It is not the HPV virus itself  that causes cervical cancer but rather a persistent state of ill-health on the  part of the patient that makes her vulnerable to persistent  infections.
 As the petition states:
 “Based on new scientific information published in the past  15 years, it is now generally agreed that identifying and typing HPV infection  does not bear a direct relationship to stratification of the risk for cervical  cancer . Most acute infections caused by HPV are self-limiting [1, 4-7].  …Repeated sequential transient HPV infections, even when caused by “high-risk”  HPVs, are characteristically not associated with high risk of developing  squamous intraepithelial lesions, a precursor of cervical  cancer.
 A woman found to be positive for the same strain (genotype)  of HPV on repeated testing is highly likely suffering from a persistent HPV  infection and is considered to be at high risk of developing precancerous  intraepithelial lesions in the cervix . It is the persistent infection, not the  virus, that determines the cancer risk.”
 The FDA agrees with this assessment of the relationship between  HPV and cervical cancer, as evidenced by its 2003 news release quoted  above.
 Next, we reveal evidence that HPV vaccines actually  cause precancerous lesions in women.
 The reclassification petition cited above also reveals that  Gardasil vaccines may increase the risk of developing precancerous lesions by  44.6 percent in some groups of women. This is found in a quote referencing a  document mentioned in the petition, which states:
 “PCR-based HPV detection device with provision for accurate  HPV genotyping is more urgently needed now because vaccination with Gardasil of  the women who are already sero-positive and PCR-positive for vaccine-relevant  genotypes of HPV has been found to increase the risk of developing high-grade  precancerous lesions by 44.6%, according to an FDA VRBPAC Background Document :  Gardasil HPV Quadrivalent Vaccine. May 18, 2006 VRBPAC Meeting. www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf”
 NewsTarget tracked down the correct URL of the document  referenced above and found it in the FDA docket archives. We have placed a safe  backup copy at: http://www.NewsTarget.com/downloads/FDA-Gardasil.pdf
 Sure enough, this document reveals startling information about  the extreme dangers apparently posed by Gardasil vaccinations. On page 13, this  document states:
 “Concerns Regarding Primary Endpoint Analyses among  Subgroups
 There were two important concerns that were identified  during the course of the efficacy review of this BLA. One was the potential for  Gardasil to enhance disease among a subgroup of subjects who had evidence of  persistent infection with vaccine-relevant HPV types at baseline. The other  concern was the observations of CIN 2/3 or worse cases due to HPV types not  contained in the vaccine. These cases of disease due to other HPV types have the  potential to counter the efficacy results of Gardasil for the HPV types  contained in the vaccine.
 1. Evaluation of the potential of Gardasil™ to enhance  cervical disease in subjects who had evidence of persistent infection with  vaccine-relevant HPV types prior to vaccination. The results of exploratory  subgroup analyses for study 013 suggested a concern that subjects who were  seropositive and PCR-positive for the vaccine-relevant HPV types had a greater  number of CIN 2/3 or worse cases as demonstrated in the following  table:
 Observed Efficacy
- 44.6%
 It appeared that subjects in this subgroup of study 013 who  received Gardasil™ might have had enhanced risk factors for development of CIN  2/3 or worse compared to placebo recipients.”
 Revealing the Dangers of Gardasil
 This revelation should be quite shocking to anyone who has been  following the debate over Gardasil and mandatory vaccinations of teenage girls.  First, it reveals that Gardasil appears to increase disease by  44.6 percent in certain people — namely, those who were already  carriers of the same HPV strains used in the vaccine.
 In other words, it appears that if the vaccine is given  to a young woman who already carries HPV in a “harmless” state, it may  “activate” the infection and directly cause precancerous lesions to  appear. The vaccine, in other words, may accelerate the development of  precancerous lesions in women.
 This is information that has simply not been made available in  the debate over Gardasil vaccination policies. The pro-vaccination rhetoric has  always been about “saving lives” and it carried the implied statement that  Gardasil is perfectly safe for all women, posing absolutely no increased risk of  cancer. What these documents reveal, however, is that Gardasil may, in fact,  pose a serious increase in the risk of cervical cancer in some recipients of the  vaccine.
 The FDA directly admits the vaccine is utterly useless in these  women, stating in the same document, “Finally, there is compelling evidence that  the vaccine lacks therapeutic efficacy among women who have had prior exposure  to HPV and have not cleared previous infection (PCR positive and  seropositive).”
 What this essentially means is that the “safe” administering of  the Gardasil vaccine requires that it be administered only to  virgins (because virtually all women who are sexually active carry HPV  strains). That, of course, would require the direct questioning of the sexual  habits of all young girls before administering the vaccine.
 Is this what the Governor of Texas really had in mind when he  mandated such vaccinations for all young girls in Texas? … a male doctor with a  vaccination needle in his hand and a thirteen-year-old girl sitting in a private  clinic room behind closed doors, with the male doctor asking her, “Have you ever  had sex?”
 Clearly, this kind of patient questioning crosses all kinds of  ethical barriers when such vaccinations are made mandatory (as  they have been made in Texas). It puts the State in the positioning of  ascertaining the sexual habits of very young teenage girls and then potentially  causing them harm. It’s not hard to suppose that most sexually active teenage  girls would claim to still be virgins (especially if their parents were  present), creating a situation where vaccines would be routinely administered to  precisely the HPV carrier subgroups for which it has been demonstrated to  greatly increase the risk of precancerous lesions.
 In other words, under a mandatory Gardasil vaccination scenario  like what exists in Texas today, a sexually-active young teenage girl has to  make a tough choice:
 1) She can lie to her doctor, claim to be a virgin, receive the  vaccine and thereby potentially increase her risk of cervical cancer.
 2) She can tell her doctor she’s sexually active, thereby  surrendering her privacy and possibly subjecting herself to various consequences  from her sexual status being learned by her parents or guardians. (One would  hope, of course, that such sexual habits were not secrets, but alas, we live in  the real world where many teenage girls do indeed have sex at a very early  age…)
 Furthermore, the young girl is unlikely to be given accurate  information about the health risks associated with the vaccine, since virtually  all health authorities are heavily involved in promoting pro-vaccination  propaganda, routinely ignoring scientific evidence that might give reasonable  people pause.
 Naturally, the better scenario here is that the young girl is  not sexually active to begin with, but in a society where 8th and 9th graders  are already routinely engaged in sexual activities — almost always unbeknownst  to their parents — it seems naive to expect that such girls would suddenly honor  pledges of celibacy in order to protect themselves from possible future dangers  posed by a present-day vaccine (especially when doctors blindly claim the  vaccine is harmless).
 There are also serious questions about the safety of the vaccine  for non-sexually-active young women. Yet even if the vaccine poses no increased  risk of cervical cancer for non-sexually-active young girls, there’s still the  more serious question of: Does the vaccine work? Does it really prevent cervical  cancer in the first place? And that question has already been clearly answered  by the FDA’s own admission that HPV infections are not the cause of cervical  cancer in the first place.
 When considering the safety and effectiveness of Gardasil  vaccinations on young teens, there are essentially four quadrants to consider,  as shown in the table below:
            | Quadrant I: Non-Sexually Active No        Gardasil Vaccine
 | Quadrant II: Non-Sexually Active Receives        Gardasil Vaccine
 | 
        | Quadrant III: Sexually Active No Gardasil        Vaccine
 | Quadrant IV: Sexually Active Receives        Gardasil Vaccine
 | 
 Based on what we’ve learned from the FDA’s own documents, here  are the likely outcomes of each of the four quadrants:
 Quadrant I: Non-Sexually Active, No Gardasil  Vaccine
Outcome: No risk of cervical cancer.
 Quadrant II: Non-Sexually Active, Receives Gardasil  Vaccine
Outcome: No medical benefit from vaccine.
 Quadrant III: Sexually Active, No Gardasil  Vaccine
Outcome: HPV presence is self-limiting and does not lead to  cervical cancer.
 Quadrant IV: Sexually Active, Receives Gardasil  Vaccine
Outcome: 44.6% Increased risk of precancerous lesions. No  reduction in cancer risk.
 In other words, Gardasil adds no benefits to any  quadrant! There is no subgroup that actually benefits from a Gardasil  vaccination. But there is at least one quadrant in which Gardasil achieves an  increased risk of disease. Put another way, Gardasil helps no one, but it harms  some.
 This is hardly a position from which to mandate the vaccine for  everyone, especially since the vaccine has been widely prescribed as “completely  safe” for everyone. It is widely claimed by medical authorities that the vaccine  has no downside: No health risks, no increased risk of disease and no potential  to cause harm in women. Clearly, these assumptions have no basis in scientific  fact.
 Keep in mind, too, that Merck, the manufacturer of Gardasil, has  publicly suggested that young boys should receive Gardasil  vaccinations! Why? Because they might engage in oral sex with girls who carry  the virus. Therefore, the story goes, young boys should be vaccinated against  this virus that they claim causes cervical cancer! (Never mind the fact that  boys don’t have a cervix…) There is no end, it seems, to the pseudoscientific  nonsense that will be spouted in an effort to sell more Garsasil vaccines to  people who don’t need them.
 To further investigate this conclusion, NewsTarget took a closer  look at research published in the Journal of the American Medical  Association (August, 2007), entitled, “Effect of Human Papillomavirus 16/18  L1 Viruslike Particle Vaccine Among Young Women With Preexisting  Infection”
 This research sought to determine the usefulness of the HPV  vaccine among women who already carry HPV (which includes virtually all women  who are sexually active, regardless of their age).
 This document can currently be found at a University of  Louisville document archive reprinted from JAMA. Click here to read the PDF yourself.
 Just in case that copy disappears, we’ve also hosted the PDF  here: http://www.newstarget.com/downloads/HPV-Vaccine-Effects.pdf
 This document reveals startling information about the  ineffectiveness of the Gardasil vaccine. It reveals that the HPV vaccine  often caused an increase in the presence of HPV strains while  utterly failing to clear the viruses in most women.
 These shocking results caused the study authors to publish this  sobering conclusion, printed in JAMA:
 “No significant evidence of a vaccine therapeutic effect was  observed in analyses restricted to women who received all doses of vaccine or  those with evidence of single HPV infections at entry (Table2). We observed no  evidence of vaccine effects when we stratified the analysis on selected study  entry characteristics reflective of [various parameters] (TABLE3). Similarly, no  evidence of vaccine effects was observed in analyses stratified by other study  entry parameters thought to potentially influence clearance rates and efficacy  of the vaccine, including time since sexual initiation, oral contraceptive use,  cigarette smoking, and concomitant infection with C trachomatis or N gonorrhoeae  (Table 3).”
 In other words, the authors found no evidence that the vaccine  worked at all. This observation led the authors to offer this damning conclusion  that appears to render Gardasil nothing more than a grand medical  hoax:
 “… rates of viral clearance over a 12-month period are not  influenced by vaccination.”
 The study goes on to state words that should cause every doctor,  Governor and health authority across the United States (and around the world) to  rethink Gardasil vaccination policies:
 “…given that viral clearance rates did not differ by  treatment group and that persistent viral infection is the best established  predictor of risk of progression, it is unlikely that vaccination could have a  significant beneficial impact on rate of lesion progression.1,17
 Results from our community-based study provide strong  evidence that there is little, if any, therapeutic benefit from the vaccine in  the population we studied. Furthermore, we see no reason to believe that there  is therapeutic benefit of the vaccine elsewhere because the biological effect of  vaccination among already infected women is not expected to vary by  population.
 In other words, the vaccines didn’t work on the population  studied, and there is no reason to believe that those same vaccines would  magically work on other populations, since the biology of women and HPV is so  similar across various populations.
 It is difficult to take an honest look at this scientific  evidence and the statements made by the FDA and not come to the conclusion that  mandatory Gardasil vaccination policies being pushed across U.S. states right  now are based on something other than science.
 There are many theories exploring the motivation for such  vaccination policies. Possible theories include:
 Financial benefit: Big Pharma is pushing  mandatory Gardasil vaccination policies so that it can profit from selling more  vaccines to the states. This idea is at least partially supported by the fact  that the first state Governor to mandate such vaccines (Texas Gov. Rick Perry)  had undisclosed ties to Big Pharma. (A top official in Perry’s administration  worked directly for Merck, the manufacturer of Gardasil.)
 Conspiracy to poison the people: This theory,  which may stretch the bounds of belief in some readers, proposes that such  mandatory vaccines are put in place in order to create future disease by  poisoning the people with dangerous chemicals and DNA fragments that are  knowingly added to vaccines. The poisoning of the people, it is said, will pay  off in future profits for Big Pharma when those people develop other serious  diseases requiring “treatment” with medications. Many people who support this  theory currently believe, for example, that AIDS was engineered by human  scientists and then administered to the gay population in New York in the late  1980’s through vaccines.
 Control the sheeple: This theory supposes that  the main purpose of mandatory vaccines is to train the American public to get  used to submitting to compulsory medicines. Once a certain segment of the  population is targeted and effectively injected with mandatory medicines, these  policies can be extended to other groups and, eventually, can encompass the  entire population.
 The first theory — Financial Benefit — is the simplest and  easiest theory to believe. It requires nothing more than simple greed on the  part of Big Pharma, along with the usual level of corruption at the FDA.  NewsTarget believes this is the most likely explanation for events surrounding  Gardasil vaccination policies, but we do not rule out other possible  explanations, either.
 Profits at Any Cost
 What’s clear in all this is that mandatory HPV vaccination  programs are not based on anything resembling good science. They seem to be  based on a carefully planted meme — an idea that, coincidentally,  spreads from one person’s mind to the next much like a virus, gaining momentum  as the mainstream media (MSM), health authorities, FDA and drug company reps  repeat the meme on a regular basis. And what is that meme? That HPV causes  cervical cancer, and, therefore, HPV vaccinations could halt cervical cancer and  save lives.
 This meme appears to have no real scientific basis. It is more  of an urban legend than anything resembling scientific fact. Furthermore, it  appears to have been conjured by those in a position to financially benefit from  the adoption of that meme (the drug companies who manufacture, sell, and profit  from the sale of HPV vaccines). In this case, that drug company is Merck, a  powerful corporation with a dubious history rife with charges of price fixing,  large-scale tax avoidance (it set up offshore accounts to avoid billions in U.S.  taxes), widespread biopiracy, conspiring with the FDA to discredit its critics,  burying negative evidence about its drugs (see the history of Vioxx at www.NewsTarget.com/vioxx.html ) and numerous  other actions that many consider to be criminal in nature.
 There is no question that Merck has the lack of ethics, the  willingness and the means to commit medical fraud on an unprecedented scale.  Based on the information revealed in this report, the mandatory vaccination of  young girls with Gardasil appears to be the boldest medical hoax yet perpetrated  by the company. You can read the true history about Merck and its crimes at:  http://www.newstarget.com/Merck.html
 NewsTarget believes Merck is currently engaged in a massive  medical fraud, and that it has influenced, corrupted or otherwise recruited FDA  officials and state health authorities in a grand scheme to sell vaccines that  are at best medically worthless, and at worst medically dangerous. Halting  cervical cancer seems to have nothing to do with the marketing and prescribing  of Gardasil. The entire campaign push for mandatory HPV vaccinations seems to be  based entirely in the realm of sales and marketing.
 The “marketing” of HPV vaccines involves classic disease  mongering — spreading fear about a disease as a way of corralling patients into  begging for the “solution” that just happens to be readily available from the  same pharmaceutical company that promoted the disease in the first place. The  hype over cervical cancer and Gardasil seems to be nothing more than a classic  case of fear-based marketing designed to create such consumer fear over cervical  cancer that a massive public outcry would result in legislation mandating the  vaccines.
 Please share this article with others.
 Permission is granted to reprint this article in its entirety,  for any non-commercial purpose, as long as full credit is given to the author  (Mike Adams) and a clearly visible clickable link is placed back to this URL at  NewsTarget.com. You may also freely quote from this article with proper  citation.
 HiFi DNA Tech files lawsuit against FDA
http://www.news-medical.net/?id=31180
 Reclassification Petition - Human Papillomavirus (HPV) DNA  Nested Polymerase Chain Reaction (PCR) Detection Device (K063649 )
http://www.fda.gov/ohrms/dockets/dockets/07p0210/07p-0210-ccp0001-01-vol1.pdf
 FDA Approves Expanded Use of HPV Test
http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html
 VRBPAC Background Document, Gardasil™ HPV Quadrivalent Vaccine,  May 18, 2006 VRBPAC Meeting
http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf
 Effect of Human Papillomavirus 16/18 L1 Viruslike Particle  Vaccine Among Young Women With Preexisting Infection
Journal of the American  Medical Association, August, 2007
  
 Source: http://www.truthnews.us/?p=1444